ArticleBiodegradation2026
Comparative performance of non-white rot fungal stirred-tank and biofilm-based bioreactors for pharmaceutical wastewater treatment: kinetic modelling and scalability potential.
Article in Biodegradation, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Pharmaceutically active compound (PhAC) is poorly removed by conventional wastewater treatment, threatening aquatic ecosystems and human health through persistent bioaccumulation. To address this challenge, we evaluated two underutilized non-white rot fungi, Aspergillus eleand Cunninghamella elegans, in stirred-tank (STBR) and biofilm-based (BBR) bioreactors for removing fluoxetine (FLX), ciprofloxacin (CIP), and atorvastatin (ATO). A. flavus in STBR achieved exceptional removal (92-94% for all PhACs), with both STBR and BBR achieving statistically comparable pharmaceutical removal efficiencies (p > 0.05). While STBR excelled in targeted PhAC degradation, BBR better improved general wastewater quality, reducing chemical oxygen demand (COD) by 73.7% and total organic carbon (TOC) by 52.6%. Surprisingly, laccase activity showed no correlation with degradation, suggesting that intracellular enzymatic mechanisms may be responsible; cytochrome P450-mediated biotransformation is proposed as a hypothesis warranting future experimental validation. These results demonstrate that non-white rot fungi offer promising, energy-efficient alternatives for pharmaceutical wastewater treatment, with bioreactor choice dependent on prioritization of specific pollutant removal versus broad effluent polishing.
Indexed as
Identifiers
41989627What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.